We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Company to Develop Rapid CSF Detection Kit

By Labmedica staff writers
Posted on 15 May 2007
A new company has been formed to develop and commercialize a rapid test for detecting cerebrospinal fluid (CSF).

NeuroPro Technologies, Inc. More...
(Modesto, CA, USA) and Pipeline Biomedical Holdings, LLC, announced that they have signed an agreement to form a new company, Pipeline-Neuro, LLC, which will exist specifically for the purpose of developing the test. Development will begin immediately.

CSF leak is an escape of the fluid that surrounds the brain and spinal cord, from the cavities within the brain, or from the central canal in the spinal cord. Current methods of positively identifying CSF take two days to two weeks for results, during which time the doctor may admit the patient and needlessly treat him/her for a CSF leak. A rapid test for detecting CSF will help emergency room clinicians detect CFS leaks that could lead to dangerous infections in the brain or spine.

NeuroPro founder and practicing neurosurgeon Benjamin J. Remington, M.D., said, Determining whether there is a CSF leak is a critical point in the diagnosis of a head injury. A quick and accurate answer helps the patient get the right treatment immediately and can help avoid unnecessary expenses.


Related Links:
NeuroPro Technologies

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.